Umeclidinium bromide, Vilanterol trifenatato

Laventair Ellipta 55 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)

65 µg + 35,2 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 29 Jul 2018

In other countries

The same active substances on other registers, the same brand first.

Laventair ElliptaCroatiaSame brand
Laventair ElliptaItaly · Polvere per inalazione · Glaxosmithkline Trading Services LimitedSame brand
Anoro ElliptaCroatiaSame substance
Anoro ElliptaItaly · Polvere per inalazione · Glaxosmithkline Trading Services LimitedSame substance
Anoro Ellipta Inhalation Powder 62.5 MCG/25 MCGSingapore · 62.5 mcg/dose + 25 mcg/dose · powder, metered · Glaxosmithkline Pte LTDSame substance
Anoro ElliptaUnited States · 0.0625MG BASE/INH; 0.025MG BASE/INH · powder · GlaxosmithklineSame substance

Packs

Pack	Code	Status

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Umeclidinium bromide, Vilanterol trifenatato

Laventair Ellipta 55 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)

65 µg + 35,2 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 29 Jul 2018

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Umeclidinium bromide, Vilanterol trifenatato
Strength: 65 µg + 35,2 µg
Dosage form: polvo para inhalación (unidosis)
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 29 Jul 2018
Registration: 114899002
Marketing authorisation holder: Glaxosmithkline Trading Services Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Umeclidinium bromide + Vilanterol trifenatato · 74,2 µg + 40 µg · polvo para inhalación (unidosis)

Spain

Anoro Ellipta 55 MCG/22 MCG Polvo Para Inhalacion (Unidosis)Umeclidinium bromide + Vilanterol trifenatato · 74,2 µg + 40 µg · polvo para inhalación (unidosis)Spain